Wadas TJ - Search Results

1

Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors.

Wadas TJ, Eiblmaier M, Zheleznyak A, Sherman CD, Ferdani R, Liang K, Achilefu S, Anderson CJ. Wadas TJ, et al. J Nucl Med. 2008 Nov;49(11):1819-27. doi: 10.2967/jnumed.108.054502. Epub 2008 Oct 16. J Nucl Med. 2008. PMID: 18927338 Free PMC article.

2

Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64.

Wadas TJ, Anderson CJ. Wadas TJ, et al. Nat Protoc. 2006;1(6):3062-8. doi: 10.1038/nprot.2006.431. Nat Protoc. 2006. PMID: 17406569

3

(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity.

Wei L, Ye Y, Wadas TJ, Lewis JS, Welch MJ, Achilefu S, Anderson CJ. Wei L, et al. Among authors: wadas tj. Nucl Med Biol. 2009 Apr;36(3):277-85. doi: 10.1016/j.nucmedbio.2008.12.008. Nucl Med Biol. 2009. PMID: 19324273 Free PMC article.

4

Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases.

Wadas TJ, Deng H, Sprague JE, Zheleznyak A, Weilbaecher KN, Anderson CJ. Wadas TJ, et al. J Nucl Med. 2009 Nov;50(11):1873-80. doi: 10.2967/jnumed.109.067140. J Nucl Med. 2009. PMID: 19875645 Free PMC article.

5

Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation.

Zheleznyak A, Wadas TJ, Sherman CD, Wilson JM, Kostenuik PJ, Weilbaecher KN, Anderson CJ. Zheleznyak A, et al. Among authors: wadas tj. Mol Imaging Biol. 2012 Aug;14(4):500-8. doi: 10.1007/s11307-011-0512-4. Mol Imaging Biol. 2012. PMID: 21853370 Free PMC article.

6

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Wadas TJ, Wong EH, Weisman GR, Anderson CJ. Wadas TJ, et al. Chem Rev. 2010 May 12;110(5):2858-902. doi: 10.1021/cr900325h. Chem Rev. 2010. PMID: 20415480 Free PMC article. Review. No abstract available.

7

The biodistribution of [153Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice.

Wadas TJ, Sherman CD, Miner JH, Duncan JR, Anderson CJ. Wadas TJ, et al. Magn Reson Med. 2010 Nov;64(5):1274-80. doi: 10.1002/mrm.22553. Magn Reson Med. 2010. PMID: 20648683 Free PMC article.

8

Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging.

Anderson CJ, Wadas TJ, Wong EH, Weisman GR. Anderson CJ, et al. Among authors: wadas tj. Q J Nucl Med Mol Imaging. 2008 Jun;52(2):185-92. Epub 2007 Nov 28. Q J Nucl Med Mol Imaging. 2008. PMID: 18043536 Free PMC article. Review.

9

Copper chelation chemistry and its role in copper radiopharmaceuticals.

Wadas TJ, Wong EH, Weisman GR, Anderson CJ. Wadas TJ, et al. Curr Pharm Des. 2007;13(1):3-16. doi: 10.2174/138161207779313768. Curr Pharm Des. 2007. PMID: 17266585 Review.

10

Macrocyclic diamide ligand systems: potential chelators for 64Cu- and 68Ga-based positron emission tomography imaging agents.

Barnard PJ, Holland JP, Bayly SR, Wadas TJ, Anderson CJ, Dilworth JR. Barnard PJ, et al. Among authors: wadas tj. Inorg Chem. 2009 Aug 3;48(15):7117-26. doi: 10.1021/ic900307f. Inorg Chem. 2009. PMID: 19588930 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters